Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)

Y. Miao; Daniela Dobre; Hiddo J. Lambers Heerspink; Michael B Brenner; M. E. Cooper; Hans Henrik Parving; Shahnaz Shahinfar; D E Grobbee; Dick de Zeeuw

doi:10.1007/s00125-011-2215-4

Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)

Y. Miao, Daniela Dobre, Hiddo J. Lambers Heerspink, Michael B Brenner, M. E. Cooper, Hans Henrik Parving, Shahnaz Shahinfar, D E Grobbee, Dick de Zeeuw

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	2209
Number of pages	1
Journal	Diabetologia
Volume	54
Issue number	8
DOIs	https://doi.org/10.1007/s00125-011-2215-4
Publication status	Published - Aug 2011
Externally published	Yes

Access to Document

10.1007/s00125-011-2215-4

Link to publication in Scopus

Cite this

Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, M. B., Cooper, M. E., Parving, H. H., Shahinfar, S., Grobbee, D. E., & de Zeeuw, D. (2011). Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6). Diabetologia, 54(8), 2209. https://doi.org/10.1007/s00125-011-2215-4

Miao, Y. ; Dobre, Daniela ; Lambers Heerspink, Hiddo J. ; Brenner, Michael B ; Cooper, M. E. ; Parving, Hans Henrik ; Shahinfar, Shahnaz ; Grobbee, D E ; de Zeeuw, Dick. / Erratum to : Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6). In: Diabetologia. 2011 ; Vol. 54, No. 8. pp. 2209.

@article{89e53cc14b37483c8837cf0f7dc4a018,

title = "Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)",

author = "Y. Miao and Daniela Dobre and {Lambers Heerspink}, {Hiddo J.} and Brenner, {Michael B} and Cooper, {M. E.} and Parving, {Hans Henrik} and Shahnaz Shahinfar and Grobbee, {D E} and {de Zeeuw}, Dick",

year = "2011",

month = aug,

doi = "10.1007/s00125-011-2215-4",

language = "English",

volume = "54",

pages = "2209",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer-Verlag London Ltd.",

number = "8",

}

Miao, Y, Dobre, D, Lambers Heerspink, HJ, Brenner, MB, Cooper, ME, Parving, HH, Shahinfar, S, Grobbee, DE & de Zeeuw, D 2011, 'Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)', Diabetologia, vol. 54, no. 8, pp. 2209. https://doi.org/10.1007/s00125-011-2215-4

Erratum to : Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6). / Miao, Y.; Dobre, Daniela; Lambers Heerspink, Hiddo J.; Brenner, Michael B; Cooper, M. E.; Parving, Hans Henrik; Shahinfar, Shahnaz; Grobbee, D E; de Zeeuw, Dick.

In: Diabetologia, Vol. 54, No. 8, 08.2011, p. 2209.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Erratum to

T2 - Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)

AU - Miao, Y.

AU - Dobre, Daniela

AU - Lambers Heerspink, Hiddo J.

AU - Brenner, Michael B

AU - Cooper, M. E.

AU - Parving, Hans Henrik

AU - Shahinfar, Shahnaz

AU - Grobbee, D E

AU - de Zeeuw, Dick

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=79960918225&partnerID=8YFLogxK

U2 - 10.1007/s00125-011-2215-4

DO - 10.1007/s00125-011-2215-4

M3 - Comment / Debate

AN - SCOPUS:79960918225

VL - 54

SP - 2209

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 8

ER -

Miao Y, Dobre D, Lambers Heerspink HJ, Brenner MB, Cooper ME, Parving HH et al. Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6). Diabetologia. 2011 Aug;54(8):2209. https://doi.org/10.1007/s00125-011-2215-4